Carregant...

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

BACKGROUND: Immunosenescence biomarkers and peripheral blood parameters are evaluated separately as possible predictive markers of immunotherapy. Here, we illustrate the use of a causal inference model to identify predictive biomarkers of CIMAvaxEGF success in the treatment of Non–Small Cell Lung Ca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Lorenzo-Luaces, Patricia, Sanchez, Lizet, Saavedra, Danay, Crombet, Tania, Van der Elst, Wim, Alonso, Ariel, Molenberghs, Geert, Lage, Agustin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7433036/
https://ncbi.nlm.nih.gov/pubmed/32807114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07284-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!